GLP-1 Use After Bariatric Surgery on the Rise (Medscape)

A large national study published in JAMA Surgery shows that GLP-1 use after bariatric surgery is rising sharply, especially among women, Black patients, and those with sleeve gastrectomy or less-than-expected weight loss. Nearly 14% of 113,000 patients turned to GLP-1s post-surgery, with uptake climbing from 1.7% in 2015–2019 to 12.6% by 2025. Physicians note it’s “logical” to combine surgery with GLP-1s, though questions remain about timing, dosing, and outcomes—fueling ongoing debate on whether these drugs will become a standard adjunct to bariatric care.